Matthew Bruno, PA C

NPI: 1194861849
Total Payments
$318,189
2024 Payments
$180,324
Companies
37
Transactions
1,898
Medicare Patients
11,043
Medicare Billing
$639,833

Payment Breakdown by Category

Other$167,295 (52.6%)
Consulting$68,919 (21.7%)
Food & Beverage$47,230 (14.8%)
Travel$33,975 (10.7%)
Education$770.33 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $157,162 113 49.4%
Consulting Fee $68,919 48 21.7%
Food and Beverage $47,230 1,624 14.8%
Travel and Lodging $33,975 93 10.7%
Honoraria $8,633 4 2.7%
Compensation for serving as faculty or as a speaker for a medical education program $1,500 2 0.5%
Education $770.33 14 0.2%

Top Paying Companies

Company Total Records Latest Year
Dermavant Sciences, Inc. $132,368 364 $0 (2024)
ABBVIE INC. $43,464 280 $0 (2024)
GENZYME CORPORATION $34,084 122 $0 (2024)
Regeneron Healthcare Solutions, Inc. $20,057 82 $0 (2024)
Amgen Inc. $14,711 106 $0 (2024)
LEO Pharma Inc. $12,360 67 $0 (2024)
Ortho Dermatologics, a division of Bausch Health US, LLC $11,963 73 $0 (2024)
MAYNE PHARMA COMMERCIAL LLC $8,168 17 $0 (2024)
E.R. Squibb & Sons, L.L.C. $6,481 61 $0 (2024)
Janssen Biotech, Inc. $6,051 91 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $180,324 715 Dermavant Sciences, Inc. ($80,583)
2023 $95,622 482 Dermavant Sciences, Inc. ($48,461)
2022 $29,634 386 ABBVIE INC. ($10,011)
2021 $12,550 312 Janssen Biotech, Inc. ($3,475)
2019 $43.00 2 Glenmark Therapeutics Inc. ($43.00)
2017 $15.59 1 Cipher Pharmaceuticals US LLC ($15.59)

All Payment Transactions

1,898 individual payment records from CMS Open Payments — Page 1 of 76

Date Company Product Nature Form Amount Type
12/31/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $12.37 General
Category: DERMATOLOGY
12/30/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $112.56 General
Category: DERMATOLOGY
12/30/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $14.26 General
Category: DERMATOLOGY
12/27/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $94.61 General
Category: DERMATOLOGY
12/21/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $10.46 General
Category: DERMATOLOGY
12/19/2024 LEO Pharma Inc. ADBRY (Biological) Consulting Fee Cash or cash equivalent $700.00 General
Category: DERMATOLOGY
12/19/2024 LEO Pharma Inc. Food and Beverage In-kind items and services $110.94 General
12/18/2024 Ortho Dermatologics, a division of Bausch Health US, LLC SILIQ (Drug) Food and Beverage In-kind items and services $16.24 General
Category: Dermatology
12/18/2024 Ortho Dermatologics, a division of Bausch Health US, LLC SILIQ (Drug) Food and Beverage In-kind items and services $8.25 General
Category: Dermatology
12/17/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $16.08 General
Category: IMMUNOLOGY
12/17/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $13.42 General
Category: Immunology
12/17/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Food and Beverage In-kind items and services $5.42 General
Category: Dermatology
12/16/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,692.00 General
Category: Inflammation
12/16/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,692.00 General
Category: Inflammation
12/16/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $564.00 General
Category: Inflammation
12/13/2024 Amgen Inc. Otezla (Drug) Travel and Lodging In-kind items and services $200.53 General
Category: Inflammation
12/13/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $125.00 General
Category: IMMUNOLOGY
12/13/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $20.45 General
Category: DERMATOLOGY
12/12/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,716.00 General
Category: INFLAMMATION AND IMMUNOLOGY
12/12/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $28.70 General
Category: Inflammation
12/11/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
12/11/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $26.08 General
Category: Inflammation
12/11/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $18.12 General
Category: IMMUNOLOGY
12/10/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $11.85 General
Category: Immunology
12/09/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $10.06 General
Category: DERMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 3,192 5,369 $1.0M $183,708
2022 23 3,019 4,923 $986,598 $179,178
2021 21 2,600 4,272 $797,905 $152,466
2020 20 2,232 3,699 $417,217 $124,482
Total Patients
11,043
Total Services
18,263
Medicare Billing
$639,833
Procedure Codes
85

All Medicare Procedures & Services

85 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 722 983 $258,555 $48,151 18.6%
17110 Destruction of skin growth, 1-14 growths Office 2023 507 626 $207,092 $38,642 18.7%
11102 Biopsy of related skin growth, first growth Office 2023 326 384 $113,767 $18,401 16.2%
17000 Destruction of precancer skin growth, 1 growth Office 2023 416 531 $103,874 $13,374 12.9%
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm Office 2023 41 48 $42,669 $9,090 21.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 148 148 $48,265 $8,490 17.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 220 266 $43,734 $8,257 18.9%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 316 1,714 $33,404 $6,723 20.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 61 81 $30,192 $5,895 19.5%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 47 56 $27,614 $5,752 20.8%
11103 Biopsy of related skin growth, each additional growth Office 2023 105 159 $23,355 $5,187 22.2%
17111 Destruction of skin growth, 15 or more growths Office 2023 55 66 $25,519 $5,153 20.2%
10060 Simple or single drainage of skin abscess Office 2023 30 32 $11,727 $2,370 20.2%
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm Office 2023 25 28 $20,036 $2,151 10.7%
11104 Punch biopsy, first skin growth Office 2023 25 26 $9,323 $1,838 19.7%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 35 35 $7,358 $1,042 14.2%
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm Office 2023 17 19 $9,538 $1,023 10.7%
69100 Biopsy of ear Office 2023 23 25 $7,049 $1,006 14.3%
11900 Injection into skin growth, 1-7 growths Office 2023 25 31 $5,165 $768.49 14.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 17 40 $1,647 $339.31 20.6%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 31 71 $229.16 $54.32 23.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 745 1,021 $271,136 $51,136 18.9%
17110 Destruction of skin growth, 1-14 growths Office 2022 486 596 $199,088 $39,092 19.6%
11102 Biopsy of related skin growth, first growth Office 2022 321 373 $112,789 $19,008 16.9%
17000 Destruction of precancer skin growth, 1 growth Office 2022 360 468 $92,411 $12,162 13.2%

About Matthew Bruno, PA C

Matthew Bruno, PA C is a Physician Assistant healthcare provider based in Allen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194861849.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Matthew Bruno, PA C has received a total of $318,189 in payments from pharmaceutical and medical device companies, with $180,324 received in 2024. These payments were reported across 1,898 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($157,162).

As a Medicare-enrolled provider, Bruno has provided services to 11,043 Medicare beneficiaries, totaling 18,263 services with total Medicare billing of $639,833. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Allen, TX
  • Active Since 01/29/2007
  • Last Updated 12/08/2025
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1194861849

Products in Payments

  • VTAMA (Drug) $113,920
  • DUPIXENT (Biological) $54,008
  • SKYRIZI (Biological) $19,759
  • TAPINAROF (Drug) $18,448
  • Otezla (Drug) $14,696
  • RINVOQ (Biological) $13,713
  • Cabtreo (Drug) $8,510
  • ADBRY (Biological) $6,198
  • TREMFYA (Drug) $5,865
  • OPZELURA (Drug) $3,400
  • Winlevi (Drug) $2,804
  • YCANTH (Drug) $2,348
  • Klisyri (Drug) $2,064
  • Bimzelx (Biological) $1,687
  • Sotyktu (Drug) $1,636
  • SILIQ (Drug) $1,615
  • WYNZORA (Drug) $1,408
  • TALTZ (Drug) $1,203
  • ILUMYA (Biological) $1,154
  • ZILXI (Drug) $1,102

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Allen